Regeneron Pharmaceuticals Inc

REGNNASDAQ • USD
ThemeBiotech - Drug Development›Immunology & Autoimmune
817.94 USD
↗ 12.27 (1.52%)🟢LIVE (AS OF 01:31 PM EDT)
🟢Market: OPEN

Regeneron Pharmaceuticals Inc (REGN) trades at $817.94 per share. Technical and fundamental signals align bullish — technicals rate "Strong Buy" while fundamentals indicate "Buy". Key drivers include a robust Altman Z-Score and a bullish Golden Cross on the moving averages. REGN is fairly valued relative to its sector peers based on current multiples.

Technical & fundamental data as of Oct 21, 2026.

Open?$809.01
High?$825.18
Low?$801.16
Prev. Close?$805.67
Volume?429.7K
Avg. Volume?718.1K
VWAP?$817.55
Rel. Volume?0.60x
Bid / Ask
Bid?$768.55 × 40
Ask?$818.83 × 40
Spread?$50.28
Midpoint?$793.69
Valuation & Ratios
Market Cap?82.9B
Shares Out?101.1M
Float?95.7M
Float %?94.6%
P/E Ratio?19.16
P/B Ratio?2.62
EPS?$42.04
Dividend?0.46%
Ex-Dividend?N/A
News
Profile
Regeneron Pharmaceuticals discovers, develops, and commercializes products that fight eye disease, cardiovascular disease, cancer, and inflammation. The company has several marketed products, including low-dose Eylea and Eylea HD, approved for wet age-related macular degeneration and other eye diseases; Dupixent in immunology; Praluent for LDL cholesterol lowering; Libtayo in oncology; Kevzara in rheumatoid arthritis; and Lynozyfic for multiple myeloma. Regeneron has multiple partnerships and collaboration agreements, with Sanofi (Dupixent, others) and Bayer (Eylea) as its largest partners.
Themes
Biotech - Drug Development›Immunology & AutoimmuneHealthcare - Oncology›Immunotherapy & Immuno-OncologyHealthcare - Genomics & Precision Medicine›Gene Therapy & Gene Editing
Employees
15.4K
Market Cap
82.9B
Industry
PHARMACEUTICAL PREPARATIONS
Website
www.regeneron.com
Listed
1991-04-02
Address
777 OLD SAW MILL RIVER ROAD
TARRYTOWN, NY 10591
Phone: (914) 847-7000
Technical OutlookStrong Buy
Strong SellNeutralStrong Buy
Long-Term (Tide)?▲ Bullish(+3/3)
Medium-Term (Wave)?▲ Bullish(+1/3)
Short-Term (Ripple)?▲ Bullish(+2/3)
MA Alignment?Mixed
Full Technical Analysis →
Fundamental OutlookBuy
Strong SellNeutralStrong Buy
F-Score?
60
Z-Score?
100
Momentum?
48
Short Sent.?
89
Piotroski F-Score?5/9Mixed
Altman Z-Score?7.28Safe
Confidence?69%Moderate
Full Fundamental Analysis →
Short InterestLow
Short % of Float?2.25%Low
Short Interest?2.2M
Days to Cover?2.5
Free Float95.7M
Avg Daily Volume863.8K
Settlement Date2026-09-30
Financial Health
Current Ratio?3.34Strong
Quick Ratio?2.78Strong
Cash Ratio?0.44Low
Debt/Equity?0.09Low
ValuationFAIRLY VALUEDvs 10 peers + S&P 500
Score
72/100
P/E?
Peers
100
S&P
68
19.2FAIR▾
P/B?
Peers
70
S&P
62
2.62CHEAP▾
P/S?
Peers
91
S&P
27
5.34FAIR▾
P/FCF?
Peers
75
S&P
48
22.1FAIR▾
EV/EBITDA?
Peers
75
S&P
29
19.1FAIR▾
EV/Sales?
Peers
82
S&P
33
5.36FAIR▾
Returns & Efficiency
ROE?
Peers
50
S&P
50
13.7%STRONG▾
ROA?
Peers
71
S&P
75
10.4%STRONG▾
Cash Flow & Enterprise
FCF?$3.8B
Enterprise Value?$83.2B
Fundamentals ratios updated end of day
MarketsMoversWatchlist